Related Articles An evaluation of the cost-effectiveness of the different palliative care models available to cancer patients in Turkey. Eur J Cancer Care (Engl). 2019 Sep;28(5):e13110 Authors: Saygili M, Çelik Y Abstract BACKGROUND: Three different models are commonly used to provide palliative care services to cancer patients in Turkey: comprehensive palliative care center (CPCC), hospital inpatient services (HIS) and home healthcare (HHC). OBJECTIVES: The purpose of this study was to evaluate the cost-effectiveness of three alternative palliative care models for cancer patients. METHODS: The study included a total of 160 patients diagnosed with cancer (CPCC:60, HIS:59, HHC:41). The patients’ quality…
Origen: An evaluation of the cost-effectiveness of the different palliative care models available to cancer patients in Turkey. – PubMed

Related Articles Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study. Int J Dermatol. 2019 Nov;58(11):1293-1299 Authors: Carrasquillo OY, Santiago-Vazquez M, Cardona R, Cruz-Manzano M, Figueroa LD Abstract BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare and potentially life-threatening mucocutaneous reactions. Given their rarity, limited cohort studies have been done. The aim of this study is to evaluate and compare the demographics, etiology, management, clinical and laboratory characteristics, complications, and outcome of SJS/TEN patients seen by the inpatient dermatology service at the University of Puerto Rico. METHODS: A retrospective review of 30 cases with identified diagnosis…
Origen: Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study. – PubMed

Related Articles A New Frontier for Palliative Care: The Need to Train Palliative-Oncology Subspecialists. J Palliat Med. 2018 12;21(12):1679-1680 Authors: Webb JA, Kamal AH, LeBlanc TW PMID: 31219413 [PubMed – indexed for MEDLINE]
Origen: A New Frontier for Palliative Care: The Need to Train Palliative-Oncology Subspecialists. – PubMed

Related Articles Feasibility of Integrating Panel-Based Pharmacogenomics Testing for Chemotherapy and Supportive Care in Patients With Colorectal Cancer. Technol Cancer Res Treat. 2019 01 01;18:1533033819873924 Authors: Kasi PM, Koep T, Schnettler E, Shahjehan F, Kamatham V, Baldeo C, Hughes CL Abstract INTRODUCTION: Pharmacogenomics is about selecting the «right drug in the right amount for the right patient.» In metastatic colorectal cancer, germline pharmacogenomics testing presents a unique opportunity to improve outcomes, since the genes dihydropyrimidine dehydrogenase and UDP-glucuronosyltransferase metabolizing the chemotherapy drugs, 5-fluorouracil, and irinotecan are already well known. In a retrospective analysis of the landmark TRIBE clinical trial [(TRIBE…
Origen: Feasibility of Integrating Panel-Based Pharmacogenomics Testing for Chemotherapy and Supportive Care in Patients With Colorectal Cancer. – PubMed

Related Articles Bilateral vs unilateral placement of metal stents for inoperable high-grade hilar biliary strictures: A systemic review and meta-analysis. World J Gastroenterol. 2019 Sep 14;25(34):5210-5219 Authors: Ashat M, Arora S, Klair JS, Childs CA, Murali AR, Johlin FC Abstract BACKGROUND: Bilateral vs unilateral biliary stenting is used for palliation in malignant biliary obstruction. No clear data is available to compare the efficacy and safety of bilateral biliary stenting over unilateral stenting. AIM: To assess the efficacy and safety of bilateral vs unilateral biliary drainage in inoperable malignant hilar obstruction. METHODS: PubMed, Embase, Scopus, and Cochrane databases, as well as…
Origen: Bilateral vs unilateral placement of metal stents for inoperable high-grade hilar biliary strictures: A systemic review and meta-analysis. – PubMed